Business Wire

New Milestone as Sweden Enshrines Policy That Can Turn World Smoke-Free

Share

Sweden has enshrined tobacco harm reduction in public health policy after becoming the first nation to prove it’s the most effective path to a smoke-free future.

Thanks to Sweden’s stance on safer nicotine alternatives, just 4.5% of Swedish-born adults now smoke - below the 5% smoke-free threshold.

This success has led Parliament to formally adopt harm reduction, reinforcing Sweden’s role as a global leader in public health innovation.

Dr. Delon Human, leader of Smoke Free Sweden, says:

“Swedes have participated in a long-running harm reduction experiment, providing undeniable proof that replacing smoking with smokeless nicotine dramatically reduces smoking-related disease, disability and premature deaths - a net gain for public health, while reducing expenditure.

“With harm reduction now policy in Sweden, every public health decision will reflect this approach. Other countries should adopt Sweden’s model without further delay.”

Rather than reducing tobacco use, Sweden now prioritises reducing harm by encouraging smokers to switch to safer alternatives like snus, nicotine pouches and vapes.

Adopted by Parliament in December 2024, the policy states:
“…tobacco policy must consider the varying harmful effects of different products. Cigarettes pose a greater health hazard than smokeless nicotine… This must be reflected in taxation and policy goals.”

Sweden has already applied risk-based taxation by lowering excise tax on snus while increasing it on cigarettes.

“Sweden’s formal adoption of harm reduction is a global milestone,” says Dr. Human. “With smoking rates at 5.3%, Sweden is set to become the first smoke-free nation. Policymakers serious about reducing smoking-related deaths must follow suit.”

Sweden’s success is remarkable. Among Swedish citizens born elsewhere in Europe, the smoking rate is 7.8% - less than a third of the EU average. The public health benefits mean Sweden has 41% fewer cancer cases than the European average and 44% lower tobacco-related mortality.

Other nations applying Sweden’s model are seeing similar results. New Zealand has nearly halved smoking rates (12.2% in 2018 to 6.9% in 2024) by promoting vaping, while Japan saw a 43% drop in cigarette sales from 2015 to 2020 as smokers switched to heated tobacco products. In the UK, nearly three million quit smoking using vapes in five years.

Dr. Human concludes: “In every tobacco control discussion, regulators should ask, ‘How have Swedes made smoking history, while saving lives?’”

View source version on businesswire.com: https://www.businesswire.com/news/home/20250325703036/en/

Contacts

Jessica Perkins
info@smokefreesweden.org

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Leading Global Battery Expert Kenneth Hoffman to Join Pure Lithium as Special Advisor21.4.2025 16:52:00 CEST | Press Release

Pure Lithium Corporation, a disruptive Boston-based vertically integrated lithium metal battery technology company, announces that Kenneth Hoffman (CFA, CIM) will join the company as a Special Advisor, leveraging his vast experience across the battery value chain to advance our drive towards full commercialization. Mr. Hoffman, who was previously Global Head of Battery Materials at McKinsey, will be a crucial asset for Pure Lithium’s commercialization strategy and development of partnerships. Working directly with Pure Lithium CEO Emilie Bodoin, he will bring a deep understanding of batteries and a unique ability to connect market dynamics with operational decision making that will be invaluable for Pure Lithium. Pure Lithium Founder and CEO Emilie Bodoin said: “I feel very privileged to bring Ken aboard at this crucial time in Pure Lithium’s evolution. He is simply one of the leading experts on batteries, forming partnerships and developing successful businesses in energy storage. We

China’s Moutai Elevates Chinese Liquor Culture onto the Global Stage21.4.2025 15:59:00 CEST | Press Release

China’s premier liquor brand Moutai captivated audiences with an impressive exhibition highlighting its global journey and the richness of Chinese liquor culture at the recently concluded 5th China International Consumer Products Expo (CICPE), or Hainan Expo 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250421891944/en/ Moutai’s pavilion at the recently concluded 5th China International Consumer Products Expo in Haikou, China. Held in Haikou, the capital of South China's Hainan Province, the five-day event welcomed over 1,700 enterprises and 4,200 consumer brands from 71 countries and regions. From technology and jewelry to gourmet food and Chinese lifestyle products, the Expo served as a vibrant showcase of global consumer trends. On this international stage, Moutai stood out as a symbol of Eastern elegance. Under the theme “Share Open Opportunities, Co-create a Better Life,” the brand spotlighted the cultural signif

Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights21.4.2025 14:05:00 CEST | Press Release

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies seeking to advance drug development, has released an in-depth report on the global clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF). The report offers strategic insights and comprehensive analysis critical for biotech and pharmaceutical companies navigating the complexities of IPF clinical research and drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250421636360/en/ Advancing IPF Clinical Research: A Global Perspective Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive lung disease characterized by the scarring of lung tissue and a steady decline in respiratory function, most commonly affecting individuals between the ages of 60 and 70. Novotech’s latest report identifies more than 800 industry-sponsored IPF c

Global Health Experts Appointed to Judge Aster Guardians Global Nursing Award 2025, to Be Held in Dubai21.4.2025 13:50:00 CEST | Press Release

Aster DM Healthcare, one of the leading integrated healthcare providers in GCC & India, has announced the distinguished Grand Jury panel for the Aster Guardians Global Nursing Award 2025 to be held in Dubai on May 26, 2025. This esteemed panel includes five leading healthcare and nursing experts: Prof. Sheila Tlou, Co-Chairperson of the Global HIV Prevention Coalition, Botswana, Special Ambassador of the African Leaders Malaria Alliance and Former Minister of Health, Botswana; Prof. James Buchan, Adjunct Professor at the WHO Collaborating Centre, University of Technology, Sydney, and Editor Emeritus of the Human Resources for Health Journal; Dr. Peter Carter, OBE Awardee and Independent Healthcare Consultant, Former CEO Central & Northwest London, NHS and Former CEO of Royal College of Nursing, UK; Dr. Niti Pall, President Elect at International Diabetes Federation, Senior Consultant at AXA EssentiAll, France and Board Chair of Harbr & Managing Director of Health4all Advisory, UK and M

MSCI and Moody's to Launch Independent Risk Assessments for Private Credit Investments21.4.2025 13:00:00 CEST | Press Release

MSCI Inc. (NYSE:MSCI) and Moody’s Corporation (NYSE:MCO) will jointly create a first-of-its-kind solution to provide independent risk assessments for private credit investments at scale. As the private credit market continues to evolve and grow, the need for consistent standards and better tools has become essential for investors to assess, compare and communicate the risk of their investments. MSCI offers a unique and comprehensive universe of high-quality private capital data, sourced from original documents provided by managers, including data on more than 2,800 private credit funds and 14,000+ individual underlying companies. As part of this joint offering, Moody’s will extend its flagship EDF-X models into MSCI’s private credit solutions. EDF-X delivers risk insights using best-in-class credit models and early warning signals to help investors assess the financial strength of public and private companies globally. The combination of Moody’s flagship EDF-X credit risk modeling solu

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye